The out-of-control, irrational exuberance that GLP-1 drugs will end Type-2 diabetes, liver (NASH, NAFLD)) and heart disease, among other projections And no, they are not "the #AI of healthcare" https://
wsj.com/finance/stocks
/the-ozempic-effect-on-wall-street-has-gone-overboard-2ce5e055?mod=Searchresults_pos1&page=1
… by @CGrantWSJ and @david_wainer
GLP-1 Drug Hype: Wall Street’s Irrational Exuberance Questioned
By
–
